학술논문
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors
Document Type
Article
Author
Source
In: Cancer Research Communications . (Cancer Research Communications, April 2024, 4(4):1165-1173)
Subject
Language
English
ISSN
27679764